Judy P. Doherty

696 total citations
7 papers, 466 citations indexed

About

Judy P. Doherty is a scholar working on Oncology, Molecular Biology and Cell Biology. According to data from OpenAlex, Judy P. Doherty has authored 7 papers receiving a total of 466 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Oncology, 2 papers in Molecular Biology and 2 papers in Cell Biology. Recurrent topics in Judy P. Doherty's work include Cell Adhesion Molecules Research (2 papers), Cellular Mechanics and Interactions (2 papers) and Cancer Cells and Metastasis (2 papers). Judy P. Doherty is often cited by papers focused on Cell Adhesion Molecules Research (2 papers), Cellular Mechanics and Interactions (2 papers) and Cancer Cells and Metastasis (2 papers). Judy P. Doherty collaborates with scholars based in Australia, United States and Ireland. Judy P. Doherty's co-authors include Robin L. Anderson, Christina M. Restall, Richard P. Redvers, Agnieszka Swierczak, John A. Hamilton, Andrew D. Cook, Jason C. Lenzo, Andy Chang, Roger R. Reddel and Lily I. Huschtscha and has published in prestigious journals such as International Journal of Radiation Oncology*Biology*Physics, International Journal of Cancer and Neoplasia.

In The Last Decade

Judy P. Doherty

7 papers receiving 459 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Judy P. Doherty Australia 7 199 182 155 132 62 7 466
Sara Kiflemariam Sweden 9 171 0.9× 287 1.6× 66 0.4× 160 1.2× 53 0.9× 10 472
Kelly Foley United States 10 357 1.8× 335 1.8× 266 1.7× 124 0.9× 54 0.9× 14 695
Kristiina Joensuu Finland 9 252 1.3× 167 0.9× 60 0.4× 126 1.0× 54 0.9× 14 414
Patricia Mendoza-García Sweden 10 166 0.8× 283 1.6× 48 0.3× 132 1.0× 107 1.7× 17 512
Wuling Zhu China 11 279 1.4× 179 1.0× 266 1.7× 39 0.3× 23 0.4× 38 498
James Ross United States 12 140 0.7× 184 1.0× 214 1.4× 91 0.7× 42 0.7× 24 559
Eva Mikaelsson Sweden 8 195 1.0× 242 1.3× 158 1.0× 35 0.3× 28 0.5× 13 493
Maja Bradic Lindh Sweden 6 224 1.1× 211 1.2× 56 0.4× 179 1.4× 58 0.9× 8 418
Maria C. Cuitiño United States 9 186 0.9× 240 1.3× 59 0.4× 75 0.6× 44 0.7× 16 445
Steffen Dickopf Germany 6 218 1.1× 276 1.5× 63 0.4× 175 1.3× 51 0.8× 9 459

Countries citing papers authored by Judy P. Doherty

Since Specialization
Citations

This map shows the geographic impact of Judy P. Doherty's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Judy P. Doherty with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Judy P. Doherty more than expected).

Fields of papers citing papers by Judy P. Doherty

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Judy P. Doherty. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Judy P. Doherty. The network helps show where Judy P. Doherty may publish in the future.

Co-authorship network of co-authors of Judy P. Doherty

This figure shows the co-authorship network connecting the top 25 collaborators of Judy P. Doherty. A scholar is included among the top collaborators of Judy P. Doherty based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Judy P. Doherty. Judy P. Doherty is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Redvers, Richard P., Marit Valla, Anna M. Bofin, et al.. (2018). Nephronectin is Correlated with Poor Prognosis in Breast Cancer and Promotes Metastasis via its Integrin-Binding Motifs. Neoplasia. 20(4). 387–400. 28 indexed citations
2.
Johnstone, Cameron N., Yvonne E. Smith, Yuan Cao, et al.. (2015). Functional and molecular characterisation of EO771.LMB tumours, a new C57BL/6-mouse-derived model of spontaneously metastatic mammary cancer. Disease Models & Mechanisms. 8(3). 237–51. 141 indexed citations
3.
Swierczak, Agnieszka, Andrew D. Cook, Jason C. Lenzo, et al.. (2014). The Promotion of Breast Cancer Metastasis Caused by Inhibition of CSF-1R/CSF-1 Signaling Is Blocked by Targeting the G-CSF Receptor. Cancer Immunology Research. 2(8). 765–776. 96 indexed citations
4.
Chang, Andy, Judy P. Doherty, Lily I. Huschtscha, et al.. (2014). STC1 expression is associated with tumor growth and metastasis in breast cancer. Clinical & Experimental Metastasis. 32(1). 15–27. 76 indexed citations
5.
Martin, Olga A., Robin L. Anderson, Prudence A. Russell, et al.. (2013). Mobilization of Viable Tumor Cells Into the Circulation During Radiation Therapy. International Journal of Radiation Oncology*Biology*Physics. 88(2). 395–403. 71 indexed citations
6.
Li, Rong, Judy P. Doherty, Sheng Chen, et al.. (2012). LIM kinase inhibition reduces breast cancer growth and invasiveness but systemic inhibition does not reduce metastasis in mice. Clinical & Experimental Metastasis. 30(4). 483–495. 40 indexed citations
7.
Restall, Christina M., et al.. (2009). A novel histone deacetylase inhibitor augments tamoxifen‐mediated attenuation of breast carcinoma growth. International Journal of Cancer. 125(2). 483–487. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026